E
Editas Medicine, Inc. (EDIT)
NMS – Real Time Price. Currency in USD
2.85
+0.11 (4.01%)
At close: Jun 26, 2026, 4:00 PM EDT
2.84
-0.01 (-0.35%)
After-hours: Jun 26, 2026, 7:25 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
2.85
+0.11 (4.01%)
At close: Jun 26, 2026, 4:00 PM EDT
2.84
-0.01 (-0.35%)
After-hours: Jun 26, 2026, 7:25 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $123.6M significantly exceed its total debt $72.0M, ensuring strong financial flexibility
Total current assets $128.1M exceed Total current liabilities $39.8M, highlighting excellent liquidity
Debt-to-equity ratio (16.3) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-23.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$23.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.22 | 6.05 | 10 | |
| Quick ratio | 3.22 | 5.63 | 10 | |
| Debt to Equity | 16.33 | 0.30 | 2.0 | |
| Debt to Assets | 0.48 | 1.04 | 5.0 | |
| Interest coverage | -23.32 | -16.91 | 1.0 | |
| Weighted average score | 5.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 20M | 78M | 32M | 41M | 39M |
| Gross Profit | 13M | 72M | 27M | 35M | 35M |
| Operating Income | -226M | -169M | -239M | -99M | -89M |
| Net Income | -220M | -153M | -237M | -160M | -109M |
| EBITDA | -220M | -163M | -233M | -94M | -85M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -16.11 | 57.34 | 5.5 |
| Next quarter | -55.75 | 1.38 | 2.0 |
| Current year | -63.47 | 44.05 | 5.5 |
| Next year | -8.89 | 4.03 | 2.5 |
| Weighted average score | 3.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -88.55 | -344.51 | -333.32 | 36.47 | 3.3 |
| Y/Y | -39.21 | 67.17 | 71.74 | 51.68 | 7.8 |
| 3y average | 87.69 | 2.75 | 10.67 | -3.71 | 5.5 |
| 5y average | 33.68 | -14.43 | -4.9 | -1.72 | 3.3 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |